Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions

30 Jun 2021

Abstract excerpt

BACKGROUND: Hepatocellular carcinoma (HCC) has a poor prognosis and has become the sixth most common malignancy worldwide due to its high incidence. Advanced approaches to therapy, including immunotherapeutic strategies, have played crucial roles in decreasing recurrence rates and improving clinical outcomes. The HCC microenvironment is important for both tumour carcinogenesis and immunogenicity, but a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34193146
DOI: 10.1186/s12935-021-02033-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictionsPMID 34193146Read ↗

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular CarcinomaSemantic proximity Read ↗

A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.Semantic proximity Read ↗

Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinomaSemantic proximity Read ↗

A novel molecular subtype identification applied to individualized treatment of mRNA vaccines for hepatocellular carcinomaSemantic proximity Read ↗

Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidatesSemantic proximity Read ↗

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular CarcinomaSemantic proximity Read ↗

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinomaSemantic proximity Read ↗

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinomaSemantic proximity Read ↗

A Novel Immune Classification Reveals Distinct Immune Escape Mechanism and Genomic Alterations: Implications for Immunotherapy in Hepatocellular CarcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.Semantic proximity Read ↗

A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinomaSemantic proximity Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.